
WALD Stock Forecast & Price Target
WALD Analyst Ratings
Bulls say
Waldencast is expected to see continued strong performance from its Obagi Skincare segment due to the brand's success in the DTC and international channels, as well as its entry into the dermal filler market. The Milk Makeup segment is facing challenges, but the company is taking steps to restructure and focus on international markets for growth. Despite ongoing investigations and elevated costs, Waldencast's strong brand appeal and growth opportunities make it an attractive stock for investment.
Bears say
Waldencast is facing challenges in both of its segments, with declining sales in its Milk Makeup brand and increased competition in the Obagi Skincare segment. Additionally, reliance on a single distributor and ongoing SEC investigation add risks to the company's future performance. With a slowing beauty market and potential inflation pressures, the company's financials could be negatively impacted. Furthermore, the concentrated ownership of shares by the SPAC sponsor may impact major decisions.
This aggregate rating is based on analysts' research of Waldencast Acquisition Corp and is not a guaranteed prediction by Public.com or investment advice.
WALD Analyst Forecast & Price Prediction
Start investing in WALD
Order type
Buy in
Order amount
Est. shares
0 shares